ARTICLE | Clinical News
huJ591 humanized antibody against PSMA regulatory update
October 30, 2000 8:00 AM UTC
Cornell Research Foundation Inc. (Ithaca, N.Y.) received U.S. Patent No. 6,136,311 covering the use of antibodies against the extracellular domain of prostate specific membrane antigen (PSMA) to treat...